newsfilter
← Latest News
Business Wire·

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

At ASM Microbe 2026, Bruker Corporation's (NASDAQ:BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis